The symptoms and the severity of the symptoms vary between individuals
It must be prescribed by a doctor
Acknowledgements This work was supported by grants from the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS, grant no
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Here at the BSS I take great pride in making my clients trust me & feel confident in their own skin
This mechanism has been demonstrated in cardiovascular research, kidney disease studies, and liver inflammation models, and the same pathway is active in the pelvic environment